Maternal serum screening for fetal trisomy 18: Benefits of patient-specific risk protocol
โ Scribed by W.Allen Hogge; Luanne Fraer; Todd Melegari
- Book ID
- 114487418
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 54 KB
- Volume
- 185
- Category
- Article
- ISSN
- 1097-6868
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The aim of this study was to evaluate the feasibility of first-trimester biochemical screening for trisomy 18, by using pregnancy-associated plasma protein A (PAPP-A) and free beta human chorionic gonadotropin (hCG) in combination with maternal age. Maternal serum levels of PAPP-A and free beta-hCG
A retrospective study on screening methods for fetal trisomy 18 has been carried out in two different laboratories using the serum parameters: total human chorionic gonadotropin (hCG), unconjugated oestriol (uE3), and -fetoprotein (AFP) in different combinations and in single marker protocols. Labor